Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC‐1 channel and by increasing intracellular calcium
- 29 January 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 150 (2), 235-247
- https://doi.org/10.1038/sj.bjp.0706954
Abstract
Given the crucial role of the skeletal muscle chloride conductance (gCl), supported by the voltage-gated chloride channel CLC-1, in controlling muscle excitability, the availability of ligands modulating CLC-1 are of potential medical as well as toxicological importance. Here, we focused our attention on niflumic acid (NFA), a molecule belonging to the fenamates group of non-steroidal anti-inflammatory drugs (NSAID). Rat muscle Cl(-) conductance (gCl) and heterologously expressed CLC-1 currents were evaluated by means of current-clamp (using two-microelectrodes) and patch-clamp techniques, respectively. Fura-2 fluorescence was used to determine intracellular calcium concentration, [Ca(2+)](i), in native muscle fibres. NFA inhibited native gCl with an IC(50) of 42 muM and blocked CLC-1 by interacting with an intracellular binding site. Additionally, NFA increased basal [Ca(2+)](i) in myofibres by promoting a mitochondrial calcium efflux that was not dependent on cyclooxygenase or CLC-1. A structure-activity study revealed that the molecular conditions that mediate the two effects are different. Pretreatment with the Ca-dependent protein kinase C (PKC) inhibitor chelerythrine partially inhibited the NFA effect. Therefore, in addition to direct channel block, NFA also inhibits gCl indirectly by promoting PKC activation. These cellular effects of NFA on skeletal muscle demonstrate that it is possible to modify CLC-1 and consequently gCl directly by interacting with channel proteins and indirectly by interfering with the calcium-dependent regulation of the channel. The effect of NFA on mitochondrial calcium stores suggests that NSAIDs, widely used drugs, could have potentially dangerous side-effects.Keywords
This publication has 51 references indexed in Scilit:
- Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormoneNeurobiology of Disease, 2006
- Activation and Inhibition of Kidney CLC-K Chloride Channels by FenamatesMolecular Pharmacology, 2005
- The Cl− channel blocker niflumic acid releases Ca2+ from an intracellular store in rat pulmonary artery smooth muscle cellsBritish Journal of Pharmacology, 2003
- Decrease in resting calcium and calcium entry associated with slow‐to‐fast transition in unloaded rat soleus muscleThe FASEB Journal, 2003
- Structural requisites of 2-(p -chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1British Journal of Pharmacology, 2003
- Modulation of the gating of ClC‐1 by S‐(–) 2‐(4‐chlorophenoxy) propionic acidBritish Journal of Pharmacology, 1999
- Regulation of the human skeletal muscle chloride channel hClC‐1 by protein kinase CThe Journal of Physiology, 1999
- A Review of the Clinical Pharmacokinetics of MeloxicamRheumatology, 1996
- Intracellular Ca2+ release by flufenamic acid and other blockers of the non‐selective cation channelFEBS Letters, 1992
- Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreasFEBS Letters, 1990